| 1 |
Ferlay J, Colombet M, Soerjomataram I，et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods [J]. Int J Cancer, 2019, 144(8): 1941-1953.
|
| 2 |
中华人民共和国国家卫生健康委员会医政司. 原发性肝癌诊疗指南(2022年版)[J/CD]. 肝癌电子杂志，2022, 9(1)：288-303.
|
| 3 |
Schlachterman A, Craft WW, Hilgenfeldt E，et al. Current and future treatments for hepatocellular carcinoma [J]. World J Gastroenterol, 2015, 21(28): 8478-8491.
|
| 4 |
曾永毅，林孔英，唐世川. 靶向联合免疫时代肝细胞癌转化治疗策略 [J]. 中华消化外科杂志，2022, 21(2): 224-230.
|
| 5 |
Ngwa W, Irabor OC, Schoenfeld JD，et al. Using immunotherapy to boost the abscopal effect [J]. Nat Rev Cancer, 2018, 18(5): 313-222.
|
| 6 |
Yu JI, Kang W, Yoo GS，et al. Safety and efficacy of liver-directed radiotherapy in combination with lenvatinib for hepatocelluar carcinoma with macroscopic tumor thrombosis [J]. Front Oncol, 2022, 12: 888755.
|
| 7 |
朱珍英，竺顺斌，陈刚，等. DC-CIK生物免疫治疗联合放疗在肝癌治疗中的临床效果[J]. 实用癌症杂志，2014, 29(11): 1436-1438.
|
| 8 |
Fu Z, Li X, Zhong J，et al. Lenvatinib in combination with transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma (uHCC): a retrospective controlled study [J]. Hepatol Int, 2021, 15(3): 663-675.
|
| 9 |
Kudo M, Ueshima K, Ikeda M，et al. Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial [J]. Gut, 2020, 69(8): 1492-1501.
|
| 10 |
邓兰，蒋益兰，江摩，等. TACE联合中药治疗原发性肝癌患者初步临床研究 [J]. 实用肝脏病杂志，2017, 20(2): 242-243.
|
| 11 |
赵东旭，张磊，姜小庆，等. HAIC是老技术还是新方法——理性看待肝动脉灌注化疗[J]. 介入放射学杂志，2022, 31(1): 2-8.
|
| 12 |
Mei J, Li SH, Li QJ, et al. Anti-PD-1 immunotherapy improves the efficacy of hepatic artery infusion chemotherapy in advanced hepatocellular carcinoma [J]. J Hepatocell Carcinoma, 2021, 8: 167-176.
|
| 13 |
He M, Li Q, Zou R，et al. Sorafenib plus hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin vs sorafenib alone for hepatocellular carcinoma with portal vein invasion: a randomized clinical trial [J]. JAMA Oncol, 2019, 5(7): 953-960.
|
| 14 |
He MK, Liang RB, Zhao Y，et al. Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy versus lenvatinib alone for advanced hepatocellular carcinoma [J]. Ther Adv Med Oncol, 2021, 13: 17588359211002720.
|
| 15 |
章浙伟，邵国良. 重视介入与靶向和免疫联合治疗在中晚期肝细胞癌中的应用前景[J]. 实用肿瘤杂志，2022, 37(3): 227-231.
|
| 16 |
Kan X, Jing Y, Wan QY，et al. Sorafenib combined with percutaneous radiofrequency ablation for the treatment of medium-sized hepatocellular carcinoma [J]. Eur Rev Med Pharmacol Sci, 2015, 19(2): 247-255.
|
| 17 |
Cui J, Wang N, Zhao H，et al. Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma [J]. Int J Cancer, 2014, 134(2): 342-351.
|
| 18 |
Couinaud C. Intrahepatic anatomy. application to liver transplantation[J]. Ann Radiol (Paris), 1994, 37(5): 323-333.
|
| 19 |
Takasaki K. Glissonean pedicle transection method for hepatic resection: a new concept of liver segmentation[J]. J Hepatobiliary Pancreat Surg, 1998, 5(3): 286-291.
|
| 20 |
Bismuth H. Surgical anatomy and anatomical surgery of the liver [J]. World J Surg, 1982, 6(1): 3-9.
|
| 21 |
Hu HJ, Jin YW, Zhou RX，et al. Hepatic artery resection for bismuth type Ⅲ and Ⅳ hilar cholangiocarcinoma: is reconstruction always required[J]. J Gastrointest Surg, 2018, 22(7): 1204-1212.
|
| 22 |
Peng C, Li C, Wen T，et al. Left hepatectomy combined with hepatic artery resection for hilar cholangiocarcinoma: a retrospective cohort study [J]. Int J Surg, 2016, 32: 167-173.
|
| 23 |
Liu R, Wang Y, Zhang XP. Revisiting human liver anatomy: dynamic watershed theory [J]. Hepatobiliary Surg Nutr, 2021, 10(1): 139-141.
|
| 24 |
刘荣，赵国栋. 肝脏解剖：从尸体静态解剖学下的树干理论到临床潜能形态学下的流域学说[J/CD]. 中华腔镜外科杂志(电子版), 2018, 11(5): 257-260.
|
| 25 |
陈洋，刘渠，刘荣. 流域学说指导下的小肝综合征处置 [J]. 解放军医学院学报，2022, 43(1): 1-5.
|
| 26 |
刘允怡，赖俊雄，刘晓欣. 钇90微球治疗原发性肝癌 [J]. 临床肝胆病杂志，2011, 27(4): 348-350.
|
| 27 |
Zhang Z, Zhang Y, Zhang L，et al. Incomplete radiofrequency ablation provokes colorectal cancer liver metastases through heat shock response by PKCα/Fra-1 pathway [J]. Cancer Biol Med, 2019, 16(3): 542-555.
|
| 28 |
Gertsch P, Vandoni RE, Pelloni A，et al. Localized hepatic ischemia after liver resection: a prospective evaluation [J]. Ann Surg, 2007, 246(6): 958-645.
|
| 29 |
宋天强. 肝脏解剖分区及命名的历史演变与展望[J]. 中国实用外科杂志，2018, 38(4): 470-472.
|
| 30 |
Majno P, Mentha G, Toso C，et al. Anatomy of the liver: an outline with three levels of complexity--a further step towards tailored territorial liver resections [J]. J Hepatol, 2014, 60(3): 654-662.
|
| 31 |
Fasel JH, Majno PE, Peitgen HO. Liver segments: an anatomical rationale for explaining inconsistencies with couinaud's eight-segment concept[J]. Surg Radiol Anat, 2010, 32(8): 761-765.
|
| 32 |
苏占亮，韩帅，张荣，等. 计算机辅助评估系统在肝脏血管变异分析中的应用价值 [J]. 实用医学影像杂志，2016, 17(2): 110-113.
|
| 33 |
Cho JY, Han HS, Choi Y，et al. Association of remnant liver ischemia with early recurrence and poor survival after liver resection in patients with hepatocellular carcinoma [J]. JAMA Surg, 2017, 152(4): 386-392.
|
| 34 |
Wang J, Zhao JP, Wang JJ，et al. The impact of bile leakage on long-term prognosis in primary liver cancers after hepatectomy: a propensity-score-matched study [J]. Asian J Surg, 2020, 43(5): 603-612.
|